Retour sur lavenir.net
   SYENSQO 80.750 € (-1,40 %)     D'IETEREN GROUP 172.800 € (-0,58 %)     AB INBEV 68.680 € (+0,06 %)     NYXOAH 1.500 € (+12,78 %)     TUBIZE-FIN 185.300 € (-0,80 %)     BREDERODE 104.400 € (+0,77 %)     BELYSSE GROUP 0.446 € (-1,98 %)     UMICORE 22.900 € (-0,52 %)     EKOPAK 3.940 € (+2,34 %)     XIOR 26.950 € (+0,56 %)     SOFINA 248.800 € (+3,49 %)     ARGENX SE 914.200 € (+1,51 %)     ONTEX GROUP 2.500 € (-2,15 %)     AZELIS GROUP 12.370 € (+0,32 %)     BEKAERT 38.500 € (-0,90 %)     COLRUYT 39.360 € (-0,66 %)     WERELDHAVE BELGIUM 51.400 € (-0,39 %)     AGEAS 75.750 € (0,00 %)     NEXTENSA 46.800 € (+1,08 %)     ONWARD MEDICAL 2.480 € (+2,27 %)     KBC 132.300 € (+1,22 %)     FAGRON 22.100 € (+0,45 %)     WDP 21.480 € (+1,32 %)     ACKERMANS V.HAAREN 269.200 € (+0,45 %)     ELIA GROUP 118.100 € (-1,25 %)     RECTICEL 12.760 € (-1,39 %)     PROXIMUS 6.320 € (+0,80 %)     BARCO 7.770 € (+0,65 %)     GBL 73.750 € (+0,68 %)     UCB 219.800 € (-0,32 %)     BPOST 1.276 € (-1,39 %)     RETAIL ESTATES 65.900 € (+0,92 %)     IBA 15.960 € (-0,62 %)     MELEXIS 65.450 € (+0,69 %)     SOLVAY 26.120 € (+1,56 %)     KBC ANCORA 94.300 € (+1,18 %)     BIOTALYS 2.370 € (-4,05 %)     GIMV 44.850 € (+4,67 %)     TITAN S.A. 53.800 € (+2,77 %)     ECONOCOM GROUP 1.530 € (-0,33 %)     VASTNED 28.700 € (+0,17 %)     KINEPOLIS GROUP 47.600 € (+1,38 %)     CENERGY 22.660 € (+2,63 %)     JENSEN-GROUP 73.400 € (-0,27 %)     ASCENCIO 52.100 € (+0,19 %)     MONTEA 64.100 € (0,00 %)     ATENOR 1.260 € (+3,28 %)     LOTUS BAKERIES 12 380.000 € (+0,65 %)     CARE PROPERTY INV. 12.400 € (+3,51 %)     CMB.TECH 16.320 € (+1,87 %)     AEDIFICA 67.000 € (+0,68 %)     VIOHALCO 16.660 € (+2,33 %)     CFE 11.300 € (+0,89 %)     CIE BOIS SAUVAGE 299.000 € (+1,36 %)     VGP 81.600 € (+1,62 %)     TINC 11.180 € (+0,90 %)     EVS 29.200 € (+1,04 %)     ORANGE BELGIUM 22.000 € (0,00 %)     DEME GROUP 182.000 € (+1,90 %)     OPTION 3.900 € (-2,50 %)  
   EXOSENS 55.800 € (-1,24 %)     FDJ UNITED 22.250 € (+0,45 %)     CVC CAPITAL 13.830 € (+1,32 %)     74SOFTWARE 39.800 € (+1,02 %)     AIRBUS 194.400 € (-1,27 %)     SCHNEIDER ELECTRIC 286.150 € (-0,21 %)     PROSUS 36.850 € (-0,01 %)     INVENTIVA 4.275 € (+4,65 %)     BIOPHYTIS 0.068 € (+28,20 %)     STELLANTIS NV 4.544 € (+0,70 %)     AIR LIQUIDE 172.580 € (+0,06 %)     ASML HOLDING 1 428.000 € (-1,23 %)     AXA 43.805 € (+1,14 %)     SOITEC 128.600 € (+14,82 %)     OENEO 9.060 € (+0,22 %)     ENGIE 23.490 € (-1,76 %)     UNILEVER 55.540 € (-0,22 %)     MAGNUM 17.040 € (+0,40 %)     ARKEMA 59.400 € (-0,75 %)     SANOFI 76.890 € (-0,35 %)     TOTALENERGIES 78.280 € (-0,03 %)     RENAULT 27.860 € (+0,61 %)     SHELL PLC 39.945 € (-0,66 %)     FORVIA 9.550 € (+6,94 %)     LVMH 429.750 € (-2,11 %)     WOLTERS KLUWER 69.480 € (+2,18 %)     AHOLD DEL 30.860 € (+0,65 %)     SAFRAN 328.400 € (-0,09 %)     ESSILORLUXOTTICA 154.950 € (-2,36 %)     KERING 243.200 € (-2,58 %)     NN GROUP 78.400 € (+0,10 %)     MAUREL ET PROM 8.205 € (+0,18 %)     ASM INTERNATIONAL 780.200 € (-2,18 %)     SCOR SE 34.180 € (-0,29 %)     BNP PARIBAS ACT.A 103.400 € (+0,29 %)     UMG 14.375 € (+0,07 %)     LEGRAND 137.850 € (+2,45 %)     HEINEKEN 72.940 € (0,00 %)     HERMES INTL 1 486.500 € (-2,97 %)     L'OREAL 379.850 € (-1,34 %)     SPINEGUARD 0.121 € (+9,37 %)     CRCAM NORM.SEINE 161.000 € (0,00 %)     ACCOR 46.080 € (-0,82 %)     VOLTALIA 5.310 € (-18,31 %)     THX PHARMA 3.860 € (-6,54 %)     SOCIETE GENERALE 73.160 € (+0,90 %)     ORANGE 15.585 € (+0,35 %)     MEDIANTECHNOLOGIES 4.150 € (-0,72 %)     ATEME 12.500 € (0,00 %)     STMICROELECTRONICS 43.980 € (+0,59 %)     LOGIC INSTRUMENT 1.900 € (+0,53 %)     DASSAULT SYSTEMES 22.400 € (+1,22 %)     WORLDLINE 14.616 € (+4,94 %)     EUROFINS SCIENT. 73.540 € (+1,04 %)     ADYEN 1 043.800 € (+0,50 %)     UNIBAIL-RODAMCO-WE 95.880 € (-0,77 %)     CHRISTIAN DIOR 391.400 € (-1,61 %)     NEXANS 138.900 € (+0,87 %)     AYVENS 11.190 € (+0,09 %)     CSG 17.088 € (-1,04 %)  
News Réglementées
02/09/2026 07:00

Infracore discloses key terms of its binding offer for the real estate of Wetzikon Hospital

Infracore SA / Key word(s): Statement
Infracore discloses key terms of its binding offer for the real estate of Wetzikon Hospital

02.09.2026 / 07:00 CET/CEST


INFRACORE SA
Press release

Infracore discloses key terms of its binding offer for the real estate of Wetzikon Hospital

Fribourg, 2 September 2026 – Infracore SA, the Swiss healthcare real estate company listed on the SIX Swiss Exchange, submitted a binding and fully financed offer to GZO AG on 29 July 2026 for the acquisition of all real estate assets of Wetzikon Hospital as part of a sale-and-leaseback transaction.

Given the advanced stage of the restructuring process, Infracore is disclosing the key terms of its offer.

Key terms of the offer:

  • purchase price of CHF 55 million in cash, payable upon confirmation of the composition agreement, with no financing condition;
  • GZO AG remains the operator of the hospital: no transfer of service mandates, operating licences, employment relationships, operating assets or patient data;
  • long-term lease agreement for 30 years, with extension options;
  • financing by Infracore of the phased completion of the unfinished extension building once GZO’s core business has been stabilised, with GZO having a preferential right to lease the premises on terms agreed in advance;
  • no capital increase by the shareholder municipalities required – the restructuring can be implemented without additional public funding;
  • Infracore’s offer provides for a substantial increase in the cash dividend to creditors.

Infracore is convinced that its offer provides a simple and robust basis for the restructuring of GZO. Infracore believes it is essential that creditors are able to compare the various restructuring options on a transparent basis. The creditors will decide on the composition agreement and, ultimately, on the proposed restructuring solution.

Eric Frey, CEO of Infracore: “Our offer is simple, fully financed and executable within the statutory timeframe: cash for creditors, full continuity for the hospital, its employees and patients – and all of this without a single franc of public funding. Under our offer, Infracore will also finance the completion of the extension building. However, we believe it is economically prudent and responsible to make these investments only once GZO’s core business has been sustainably stabilised following completion of the restructuring process. Particularly in the current environment, the careful use of financial resources is essential.”

Media contact

Urs Grob, ugr@dynamicsgroup.ch, +41 79 550 48 59

About Infracore SA
Infracore SA is one of Switzerland’s leading owners of healthcare infrastructure. The company owns and develops a real estate portfolio dedicated to the healthcare sector. Its business model is based on long-term lease agreements with hospital and healthcare operators, providing high visibility of rental income and direct exposure to the growing need for modern healthcare infrastructure in Switzerland. Infracore is listed in accordance with the Standard for Real Estate Companies of the SIX Swiss Exchange (INFRAC.SW). www.infracore.ch

 


Additional features:

File: Infracore_Communique_GZO_EN_2.9.2026


End of Media Release
View original content: EQS News


Language:English
Company:Infracore SA
Rue Georges-Jordil 4
1700 Fribourg
Switzerland
Phone:+41 26 350 02 10
E-mail:investor@infracore.ch
Internet:www.infracore.ch
ISIN:CH0019867685
EQS News ID:2392106

 
End of NewsEQS News Service

2392106  02.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière